tailieunhanh - In search of druggable targets for GBM amino acid metabolism

Several AA-metabolizing enzymes that are higher in GBM, are also linked to poor outcome (such as BCAT1), which makes them potential targets for therapeutic inhibition. Moreover, existing drugs that deplete asparagine and arginine may be effective against brain tumors, and should be studied in conjunction with chemotherapy. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN